FDA Approves BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE — Actavis Pharma, Inc.

Actavis Pharma has confirmed the continued availability of the approved brand and generically equivalent Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate (NDA020232), a 3-A controlled substance combination therapy first approved in 1992. The maintenance of both brand and generic market Access is critical for meeting ongoing patient demand for relief from tension headaches and migraines.